Blocking TXNIP reduced IL-1β Induced chondrocyte cell inflammation

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by articular cartilage breakdown.
• Interleukin 1β (IL-1β) plays a key role in chondrocyte injury and OA progression.
• TXNIP (Thioredoxin-interacting protein) is implicated in cellular stress and inflammation, but its role in OA is not fully understood.

Purpose of the Study:

• To investigate the role of TXNIP in IL-1β-induced chondrocyte injury and OA progression.
• To elucidate the molecular mechanisms by which TXNIP regulates chondrocyte apoptosis, aging, and proliferation.
• To assess the therapeutic potential of TXNIP inhibition in OA.

Main Methods:

• Primary mouse chondrocytes were cultured and treated with IL-1β.
• TXNIP expression was analyzed using immunohistochemistry and qRT-PCR.
• TXNIP was silenced using lentiviral vectors (shTXNIP).
• Cell proliferation, apoptosis, and aging were assessed using CCK-8 assay, flow cytometry, and staining kits.
• Gene and protein expression of inflammatory markers (TNF, IL-6), matrix-degrading enzymes (MMP3, MMP13, ADAMTS-5), type II collagen, and signaling proteins (P-ERK, NLRP3, Caspase1) were analyzed via RT-PCR and Western blot.

Main Results:

• IL-1β treatment increased TXNIP expression in chondrocytes in a dose-dependent manner.
• Silencing TXNIP significantly enhanced chondrocyte proliferation.
• TXNIP inhibition reduced IL-1β-induced chondrocyte apoptosis and aging.
• Downregulation of TXNIP decreased the expression of pro-inflammatory genes (TNF, IL-6) and matrix-degrading enzymes (MMP3, MMP13, ADAMTS-5), and increased type II collagen expression.
• While P-ERK expression remained largely unchanged, NLRP3 and Caspase1 protein levels were reduced upon TXNIP silencing.

Conclusions:

• TXNIP plays a critical role in IL-1β-induced chondrocyte apoptosis and aging.
• Silencing TXNIP demonstrates a protective effect on chondrocytes, promoting proliferation and reducing degenerative markers.
• TXNIP inhibition represents a potential therapeutic strategy for osteoarthritis.
• The precise molecular signaling pathway regulated by TXNIP in OA requires further investigation.